dexrazoxane has been researched along with Fibrosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, S; Fuhrmann, D; Gödtel-Armbrust, U; Kaina, B; Nemecek, A; Nikolova, T; Wojnowski, L; Yan, T | 1 |
1 other study(ies) available for dexrazoxane and Fibrosarcoma
Article | Year |
---|---|
The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
Topics: Activating Transcription Factor 3; Antigens, Neoplasm; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Dexrazoxane; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Fibrosarcoma; Histones; Humans; Intracellular Signaling Peptides and Proteins; Poly-ADP-Ribose Binding Proteins; RNA Interference; Signal Transduction; Time Factors; Topoisomerase II Inhibitors; Transfection; Tumor Suppressor p53-Binding Protein 1; Tumor Suppressor Protein p53 | 2015 |